These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 21596890)

  • 1. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells.
    Zhao ZA; Zhang ZR; Xu X; Deng WB; Li M; Leng JY; Liang XH; Yang ZM
    Fertil Steril; 2012 May; 97(5):1199-205.e1-9. PubMed ID: 22369775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ; Ki SH; Brooks C; Kim SG
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
    Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
    Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
    Cho IJ; Sung DK; Kang KW; Kim SG
    Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
    Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
    Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
    Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
    J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer-binding protein-β participates in oxidized LDL-enhanced proliferation in 3T3-L1 cells.
    Santangelo C; Varì R; Scazzocchio B; Filesi C; D'Archivio M; Giovannini C; Masella R
    Biochimie; 2011 Sep; 93(9):1510-9. PubMed ID: 21621583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
    Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
    Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
    Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
    Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.
    Wang YD; Yang F; Chen WD; Huang X; Lai L; Forman BM; Huang W
    Mol Endocrinol; 2008 Jul; 22(7):1622-32. PubMed ID: 18436567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program.
    Lee MY; Kong HJ; Cheong J
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1241-7. PubMed ID: 11243868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
    Klick DE; Shadley JD; Hines RN
    Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.